Covered recipient · General Payments record
MICHELLE SIRMAN-WELLS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2025
$3,146.12
- Reported across 39 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,084.24 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $250.19 | 2 |
| Madrigal Pharmaceuticals | $146.48 | 1 |
| Alnylam Pharmaceuticals Inc. | $141.24 | 1 |
| ABBVIE INC. | $125.01 | 1 |
| SANOFI-AVENTIS U.S. LLC | $124.99 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.56 | 1 |
| Gilead Sciences, Inc. | $109.66 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $71.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.01 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203455071 | CMS |
| Alnylam Pharmaceuticals Inc. | $141.24 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212749859 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $71.11 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225805940 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.56 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222849942 | CMS |
| Gilead Sciences, Inc. | $109.66 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234397894 | CMS |
| Madrigal Pharmaceuticals | $146.48 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248382557 | CMS |
| Novo Nordisk Inc | $125.00 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188943154 | CMS |
| Novo Nordisk Inc | $125.19 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188472716 | CMS |
| SANOFI-AVENTIS U.S. LLC | $124.99 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233567569 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.